 | • レポートコード：QY2207C3665 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の細胞＆遺伝子治療製造サービスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に細胞＆遺伝子治療製造サービスの世界市場のxxx％を占める「同種異系」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「腫瘍性疾患」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の細胞＆遺伝子治療製造サービスの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの細胞＆遺伝子治療製造サービス市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの細胞＆遺伝子治療製造サービス市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 細胞＆遺伝子治療製造サービスのグローバル主要メーカーには、Thermo Fisher Scientific、Merck KGaA、Charles River Laboratories、Lonza、Catalent、WuXi AppTec、Takara Bio Inc、Nikon Corporation、FUJIFILM Holdings Corporation、F. Hoffmann-La Roche、Oxford Biomedica Plc、Cell and Gene Therapy Catapult、The Discovery Labs LLC、RoslinCT、JRS PHARMA、FinVector、ABL、Resilience、BioCentriq、Porton Biopharma Limited、Andelyn Biosciences、Commercializing Living Therapies、Vibalogics、Anemocyte Srl、ElevateBioなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 細胞＆遺伝子治療製造サービス市場は、種類と用途によって区分されます。世界の細胞＆遺伝子治療製造サービス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 同種異系、自家、ウイルスベクター 【用途別セグメント】 腫瘍性疾患、心血管疾患、整形外科疾患、眼科疾患、感染症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 細胞＆遺伝子治療製造サービス製品概要 - 種類別市場（同種異系、自家、ウイルスベクター） - 用途別市場（腫瘍性疾患、心血管疾患、整形外科疾患、眼科疾患、感染症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の細胞＆遺伝子治療製造サービス販売量予測2017-2028 - 世界の細胞＆遺伝子治療製造サービス売上予測2017-2028 - 細胞＆遺伝子治療製造サービスの地域別販売量 - 細胞＆遺伝子治療製造サービスの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別細胞＆遺伝子治療製造サービス販売量 - 主要メーカー別細胞＆遺伝子治療製造サービス売上 - 主要メーカー別細胞＆遺伝子治療製造サービス価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（同種異系、自家、ウイルスベクター） - 細胞＆遺伝子治療製造サービスの種類別販売量 - 細胞＆遺伝子治療製造サービスの種類別売上 - 細胞＆遺伝子治療製造サービスの種類別価格 ・用途別市場規模（腫瘍性疾患、心血管疾患、整形外科疾患、眼科疾患、感染症、その他） - 細胞＆遺伝子治療製造サービスの用途別販売量 - 細胞＆遺伝子治療製造サービスの用途別売上 - 細胞＆遺伝子治療製造サービスの用途別価格 ・北米市場 - 北米の細胞＆遺伝子治療製造サービス市場規模（種類別、用途別） - 主要国別の細胞＆遺伝子治療製造サービス市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの細胞＆遺伝子治療製造サービス市場規模（種類別、用途別） - 主要国別の細胞＆遺伝子治療製造サービス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の細胞＆遺伝子治療製造サービス市場規模（種類別、用途別） - 主要国別の細胞＆遺伝子治療製造サービス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の細胞＆遺伝子治療製造サービス市場規模（種類別、用途別） - 主要国別の細胞＆遺伝子治療製造サービス市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの細胞＆遺伝子治療製造サービス市場規模（種類別、用途別） - 主要国別の細胞＆遺伝子治療製造サービス市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher Scientific、Merck KGaA、Charles River Laboratories、Lonza、Catalent、WuXi AppTec、Takara Bio Inc、Nikon Corporation、FUJIFILM Holdings Corporation、F. Hoffmann-La Roche、Oxford Biomedica Plc、Cell and Gene Therapy Catapult、The Discovery Labs LLC、RoslinCT、JRS PHARMA、FinVector、ABL、Resilience、BioCentriq、Porton Biopharma Limited、Andelyn Biosciences、Commercializing Living Therapies、Vibalogics、Anemocyte Srl、ElevateBio ・産業チェーン及び販売チャネル分析 - 細胞＆遺伝子治療製造サービスの産業チェーン分析 - 細胞＆遺伝子治療製造サービスの原材料 - 細胞＆遺伝子治療製造サービスの生産プロセス - 細胞＆遺伝子治療製造サービスの販売及びマーケティング - 細胞＆遺伝子治療製造サービスの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 細胞＆遺伝子治療製造サービスの産業動向 - 細胞＆遺伝子治療製造サービスのマーケットドライバー - 細胞＆遺伝子治療製造サービスの課題 - 細胞＆遺伝子治療製造サービスの阻害要因 ・主な調査結果 |
Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).
Market Analysis and Insights: Global Cell and Gene Therapy Manufacturing Services Market
The global Cell and Gene Therapy Manufacturing Services market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, By Cell Therapy accounting for % of the Cell and Gene Therapy Manufacturing Services global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology Diseases segment is altered to an % CAGR throughout this forecast period.
China Cell and Gene Therapy Manufacturing Services market size is valued at US$ million in 2021, while the North America and Europe Cell and Gene Therapy Manufacturing Services are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cell and Gene Therapy Manufacturing Services landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell and Gene Therapy Manufacturing Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell and Gene Therapy Manufacturing Services market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell and Gene Therapy Manufacturing Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell and Gene Therapy Manufacturing Services market.
Global Cell and Gene Therapy Manufacturing Services Scope and Market Size
Cell and Gene Therapy Manufacturing Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cell and Gene Therapy Manufacturing Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
By Cell Therapy
Allogeneic
Autologous
Viral Vector
By Gene Therapy
Non-viral Vector
Oligonucleotides
Viral Vector
Segment by Application
Oncology Diseases
Cardiovascular Diseases
Orthopedic Diseases
Ophthalmology Diseases
Infectious Diseases
Others
By Company
Thermo Fisher Scientific
Merck KGaA
Charles River Laboratories
Lonza
Catalent
WuXi AppTec
Takara Bio Inc
Nikon Corporation
FUJIFILM Holdings Corporation
F. Hoffmann-La Roche
Oxford Biomedica Plc
Cell and Gene Therapy Catapult
The Discovery Labs LLC
RoslinCT
JRS PHARMA
FinVector
ABL
Resilience
BioCentriq
Porton Biopharma Limited
Andelyn Biosciences
Commercializing Living Therapies
Vibalogics
Anemocyte Srl
ElevateBio
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Allogeneic
1.2.3 Autologous
1.2.4 Viral Vector
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology Diseases
1.3.3 Cardiovascular Diseases
1.3.4 Orthopedic Diseases
1.3.5 Ophthalmology Diseases
1.3.6 Infectious Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing Services Market Perspective (2017-2028)
2.2 Cell and Gene Therapy Manufacturing Services Growth Trends by Region
2.2.1 Cell and Gene Therapy Manufacturing Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell and Gene Therapy Manufacturing Services Historic Market Size by Region (2017-2022)
2.2.3 Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Region (2023-2028)
2.3 Cell and Gene Therapy Manufacturing Services Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing Services Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing Services Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing Services Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue (2017-2022)
3.1.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Players (2017-2022)
3.2 Global Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing Services Revenue
3.4 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing Services Revenue in 2021
3.5 Cell and Gene Therapy Manufacturing Services Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing Services Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing Services Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Type (2017-2022)
4.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Type (2023-2028)
5 Cell and Gene Therapy Manufacturing Services Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Application (2017-2022)
5.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
6.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Type
6.2.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
6.2.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
6.2.3 North America Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
6.3 North America Cell and Gene Therapy Manufacturing Services Market Size by Application
6.3.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
6.3.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
6.3.3 North America Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
6.4 North America Cell and Gene Therapy Manufacturing Services Market Size by Country
6.4.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
6.4.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
7.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type
7.2.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
7.2.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
7.2.3 Europe Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
7.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application
7.3.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
7.3.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
7.3.3 Europe Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
7.4 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country
7.4.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
7.4.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type
8.2.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application
8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region
8.4.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
9.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type
9.2.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
9.2.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
9.2.3 Latin America Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
9.3 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application
9.3.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
9.3.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
9.3.3 Latin America Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
9.4 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country
9.4.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
9.4.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type
10.2.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application
10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country
10.4.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Introduction
11.2.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.2.5 Merck KGaA Recent Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Introduction
11.3.4 Charles River Laboratories Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.3.5 Charles River Laboratories Recent Developments
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza Cell and Gene Therapy Manufacturing Services Introduction
11.4.4 Lonza Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.4.5 Lonza Recent Developments
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent Cell and Gene Therapy Manufacturing Services Introduction
11.5.4 Catalent Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.5.5 Catalent Recent Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Introduction
11.6.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.6.5 WuXi AppTec Recent Developments
11.7 Takara Bio Inc
11.7.1 Takara Bio Inc Company Details
11.7.2 Takara Bio Inc Business Overview
11.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Introduction
11.7.4 Takara Bio Inc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.7.5 Takara Bio Inc Recent Developments
11.8 Nikon Corporation
11.8.1 Nikon Corporation Company Details
11.8.2 Nikon Corporation Business Overview
11.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Introduction
11.8.4 Nikon Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.8.5 Nikon Corporation Recent Developments
11.9 FUJIFILM Holdings Corporation
11.9.1 FUJIFILM Holdings Corporation Company Details
11.9.2 FUJIFILM Holdings Corporation Business Overview
11.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Introduction
11.9.4 FUJIFILM Holdings Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.9.5 FUJIFILM Holdings Corporation Recent Developments
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Details
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.10.5 F. Hoffmann-La Roche Recent Developments
11.11 Oxford Biomedica Plc
11.11.1 Oxford Biomedica Plc Company Details
11.11.2 Oxford Biomedica Plc Business Overview
11.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Introduction
11.11.4 Oxford Biomedica Plc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.11.5 Oxford Biomedica Plc Recent Developments
11.12 Cell and Gene Therapy Catapult
11.12.1 Cell and Gene Therapy Catapult Company Details
11.12.2 Cell and Gene Therapy Catapult Business Overview
11.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Introduction
11.12.4 Cell and Gene Therapy Catapult Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.12.5 Cell and Gene Therapy Catapult Recent Developments
11.13 The Discovery Labs LLC
11.13.1 The Discovery Labs LLC Company Details
11.13.2 The Discovery Labs LLC Business Overview
11.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Introduction
11.13.4 The Discovery Labs LLC Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.13.5 The Discovery Labs LLC Recent Developments
11.14 RoslinCT
11.14.1 RoslinCT Company Details
11.14.2 RoslinCT Business Overview
11.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Introduction
11.14.4 RoslinCT Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.14.5 RoslinCT Recent Developments
11.15 JRS PHARMA
11.15.1 JRS PHARMA Company Details
11.15.2 JRS PHARMA Business Overview
11.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Introduction
11.15.4 JRS PHARMA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.15.5 JRS PHARMA Recent Developments
11.16 FinVector
11.16.1 FinVector Company Details
11.16.2 FinVector Business Overview
11.16.3 FinVector Cell and Gene Therapy Manufacturing Services Introduction
11.16.4 FinVector Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.16.5 FinVector Recent Developments
11.17 ABL
11.17.1 ABL Company Details
11.17.2 ABL Business Overview
11.17.3 ABL Cell and Gene Therapy Manufacturing Services Introduction
11.17.4 ABL Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.17.5 ABL Recent Developments
11.18 Resilience
11.18.1 Resilience Company Details
11.18.2 Resilience Business Overview
11.18.3 Resilience Cell and Gene Therapy Manufacturing Services Introduction
11.18.4 Resilience Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.18.5 Resilience Recent Developments
11.19 BioCentriq
11.19.1 BioCentriq Company Details
11.19.2 BioCentriq Business Overview
11.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Introduction
11.19.4 BioCentriq Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.19.5 BioCentriq Recent Developments
11.20 Porton Biopharma Limited
11.20.1 Porton Biopharma Limited Company Details
11.20.2 Porton Biopharma Limited Business Overview
11.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Introduction
11.20.4 Porton Biopharma Limited Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.20.5 Porton Biopharma Limited Recent Developments
11.21 Andelyn Biosciences
11.21.1 Andelyn Biosciences Company Details
11.21.2 Andelyn Biosciences Business Overview
11.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Introduction
11.21.4 Andelyn Biosciences Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.21.5 Andelyn Biosciences Recent Developments
11.22 Commercializing Living Therapies
11.22.1 Commercializing Living Therapies Company Details
11.22.2 Commercializing Living Therapies Business Overview
11.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Introduction
11.22.4 Commercializing Living Therapies Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.22.5 Commercializing Living Therapies Recent Developments
11.23 Vibalogics
11.23.1 Vibalogics Company Details
11.23.2 Vibalogics Business Overview
11.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Introduction
11.23.4 Vibalogics Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.23.5 Vibalogics Recent Developments
11.24 Anemocyte Srl
11.24.1 Anemocyte Srl Company Details
11.24.2 Anemocyte Srl Business Overview
11.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Introduction
11.24.4 Anemocyte Srl Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.24.5 Anemocyte Srl Recent Developments
11.25 ElevateBio
11.25.1 ElevateBio Company Details
11.25.2 ElevateBio Business Overview
11.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Introduction
11.25.4 ElevateBio Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.25.5 ElevateBio Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer